ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 2 filers reported holding ACORDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $114,000 | -13.0% | 164,506 | -35.5% | 0.00% | -33.3% |
| Q3 2020 | $131,000 | -48.4% | 255,106 | -26.1% | 0.00% | -40.0% |
| Q2 2020 | $254,000 | +43.5% | 345,106 | +81.5% | 0.01% | +25.0% |
| Q1 2020 | $177,000 | -74.3% | 190,106 | -43.6% | 0.00% | -55.6% |
| Q4 2019 | $688,000 | +21.8% | 337,106 | +71.1% | 0.01% | +12.5% |
| Q3 2019 | $565,000 | -62.6% | 197,000 | 0.0% | 0.01% | -57.9% |
| Q2 2019 | $1,511,000 | -47.6% | 197,000 | -9.2% | 0.02% | -47.2% |
| Q1 2019 | $2,884,000 | -14.7% | 217,000 | 0.0% | 0.04% | -20.0% |
| Q4 2018 | $3,381,000 | – | 217,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |